PhRMA and BIO say Biden’s march-in pro­pos­al cre­ates un­cer­tain­ty in in­dus­try

PhRMA pres­i­dent Stephen Ubl ar­gued Thurs­day that the Biden ad­min­is­tra­tion’s new pro­pos­al on the use of march-in rights has “plant­ed the seeds of un­cer­tain­ty” around …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER